COVID-19 Vaccine In Pregnancy and Lactation (COVIPAL)
To address the lack of data on vaccine efficacy and safety in pregnant and lactating populations, our team is launching a study of immune response and pregnancy outcomes after COVID-19 Vaccine in Pregnancy and Lactation (COVIPAL).
Pregnancy Cohort
Eligibility:
- Currently pregnant and planning to deliver at UCSF Medical Center.
- Planning to receive a COVID-19 vaccine or booster.
- Willing to be followed for up to 1 year after delivery.
Study overview:
- Surveys about your health, response to vaccine, and your experience related to COVID-19 and vaccination for up to 1 year after birth.
- Specimen donation:
- Your blood samples (at the time of vaccination, during pregnancy, and at the time of delivery)
- Placenta
- Cord blood
- Breastmilk
- Infant blood
- Review of medical records
Lactation Cohort
Eligibility:
- Currently or planning to breastfeed.
- Willing to come to UCSF for blood draws.
- Planning to receive a COVID-19 vaccine or booster.
- Willing to be followed for up to 1 year after vaccination.
Study overview:
- Surveys about your health, response to vaccine, and personal experiences related to COVID-19 and vaccination for up to 1 year after vaccination.
- Specimen donation:
- Your blood samples (before and after vaccination)
- Breastmilk
- Infant blood
- Review of medical records
FAQs
Can I get the vaccine through participation in the study?
I was vaccinated prior to pregnancy, but I am currently pregnant and planning to get a booster. Am I eligible?
I was vaccinated during my recent pregnancy, and I am planning to get a booster. Am I eligible?
How many people will participate in the study?
Is there compensation for participating in the study?
Can I get my antibody results through participation in the study?
How long will the study be running?
When will results of the study be available?
Other questions? Contact us.